Added to YB: 2024-02-16
Pitch date: 2024-02-15
CLPT [bullish]
ClearPoint Neuro, Inc.
+26.93%
current return
Author Info
No bio for this author
Company Info
ClearPoint Neuro, Inc., a commercial-stage medical device company, focuses on the development and commercialization of platforms for performing minimally invasive surgical procedures in the brain in the United States.
Market Cap
$272.3M
Pitch Price
$7.39
Price Target
N/A
Dividend
N/A
EV/EBITDA
-14.10
P/E
-10.18
EV/Sales
7.70
Sector
Health Care Equipment and Supplies
Category
growth
ClearPoint Neuro: Potential Inflection Point
CLPT: MRI-guided neuro surgery co. sees $12B mkt opp in 140K+ procedures. Partners like Spark in trials. New laser & OR systems for 2024 launch to drive growth. Q4 rev +23% YoY, 17-33% growth projected for '24. $24M cash, breakeven goal 2H '25. Risks: complex diseases, competition.
Read full article (9 min)